% | $
Quotes you view appear here for quick access.

Zalicus AŞ Message Board

  • tabecounted1 tabecounted1 Sep 12, 2013 7:17 PM Flag


    I'm not even for it! Settle now---and the dream is over-jmho. the window seems to be getting smaller with run-up....Not that there isn't time---BUT WHO IN THE HECK IS SELLING!!! Been gone most of the day--ouch--I'm getting tired of making excuses for this stock. But---i DON'T WANT AN R/S!!!NO WAY-NO HOW!

    LONG TERM SENTIMENT------WHO IN THE HECK KNOWS!!!! Getting like John Lennon here.....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Jason Napodano said,
      We suspect that Zalicus will look to partner Z160 in a deal similar to the previous collaboration with Merck following results of the two ongoing phase 2a trials. Management told us partners are already knocking on the door for Z160. We think with two positive Phase 2a trials in hand, Zalicus will be able to secure a very lucrative deal. For the sake of argument, let's assume Z160 is a $1 billion drug, with a 20% chance to make it to the market in 2018. That could be worth $50 million upfront to a big pharmaceutical company in early 2014, along with $250 million in reasonable back-end potential plus a mid-teen to low-twenty percent royalty on sales. With a current market capitalization of only $82 million, we think it is fair to say that this sort of transaction is certainly not priced into the shares today.

      Sentiment: Strong Buy

    • Tab, no one wants R/S. Per Q2 10Q, Zalicus has until Oct 21to regain compliance with NASDAQ and as of June 30 Zalicus sold 6.1M shares to LPC, with LPC buying, we expect good news soon!

      Sentiment: Strong Buy

    • chevelle_69 Sep 12, 2013 7:29 PM Flag

      I'm with you Tab! No R/S! She's gonna run next week!

      Do you think management has too much insider info now on Z160 that they couldn't buy? Seems like if 1 of them purchased some shares right now it would help tremendously.